131 results
8-K
EX-99.1
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
business; the fact that Fortress Biotech, Inc. controls a majority of the voting power of our outstanding capital stock and has rights to receive
8-K
EX-3.1
ATXI
Avenue Therapeutics Inc
26 Apr 24
Avenue Therapeutics Announces Reverse Stock Split
4:39pm
of Incorporation and declaring said amendment to be advisable.
THIRD. That this amendment was duly authorized by the holders of a majority
DEF 14C
ATXI
Avenue Therapeutics Inc
18 Mar 24
Information statement
4:59pm
Concourse, Suite 301
Bay Harbor Islands, Florida 33154
NOTICE OF ACTION TAKEN BY WRITTEN CONSENT OF THE HOLDERS OF A MAJORITY OF THE VOTING POWER … pursuant to a written consent executed by stockholders representing a majority of the voting power of our capital stock in lieu of a meeting
8-K
EX-99.1
pg3z 3v3v
18 Mar 24
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
4:10pm
PRE 14C
s5g6at2nj p96900mrnb
8 Mar 24
Preliminary information
4:31pm
8-K
1wx214q4jdrr 7eu4
8 Mar 24
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
sa40vezd
23 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:17pm
8-K
EX-3.1
3s3irj5ah2q5pbmzydoz
23 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:17pm
424B3
4ayl4 2xgqfozk1dv
2 Feb 24
Prospectus supplement
12:00am
DEF 14C
ei4uz 8wywkiromz
29 Jan 24
Information statement
8:00am
PRE 14C
9rekii
17 Jan 24
Preliminary information
5:05pm
8-K
d7uk520knuvcdqgn
12 Jan 24
Submission of Matters to a Vote of Security Holders
6:01am
8-K
EX-4.2
5v94tdnwpuw xz9onf
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-4.1
7w38u 5oln4
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-10.2
dxfzsqgf 6ntgc
8 Jan 24
Entry into a Material Definitive Agreement
5:28pm